Chi I C
Family Health International, Research Triangle Park, North Carolina 27709.
Contraception. 1991 Dec;44(6):573-88. doi: 10.1016/0010-7824(91)90078-t.
The levonorgestrel-releasing IUD (LNG-IUD-20), providing a daily dose of 20 ug, has recently been approved for marketing in Finland. The IUD's high efficacy in preventing accidental pregnancy and other numerous positive features make it a promising contraceptive device for worldwide use, just like the currently available T-shaped copper-releasing (TCu) IUDs. This paper reviews published reports comparing the LNG-IUD-20 and the currently used TCu IUDs. The merits and disadvantages of the steroid-releasing IUD are evaluated in terms of its performance and other special features relative to the TCu IUDs. Also, a number of future studies with medical and programmatic importance are proposed. A broader understanding about these two IUD families will facilitate their use in a complementary way for family planning programs.
每日释放20微克左炔诺孕酮的宫内节育器(LNG-IUD-20)最近已在芬兰获批上市。该宫内节育器在预防意外怀孕方面效果显著,还有诸多其他优点,这使其成为一种有望在全球范围内使用的避孕器械,就如同现有的T型含铜宫内节育器(TCu IUD)一样。本文回顾了已发表的比较LNG-IUD-20与当前使用的TCu IUD的报告。从其性能以及相对于TCu IUD的其他特点方面,对释放类固醇的宫内节育器的优缺点进行了评估。此外,还提出了一些具有医学和项目重要性的未来研究。对这两类宫内节育器有更广泛的了解将有助于以互补方式将它们用于计划生育项目。